Advertisement

Topics

MicroMed Cardiovascular Company Profile

13:49 EDT 23rd September 2018 | BioPortfolio

In 1984, Dr. Michael DeBakey and Dr. George Noon performed heart transplant surgery on NASA-Johnson Space Center (JSC) engineer David Saucier, following a severe heart attack. Six months later, Saucier returned to JSC with the desire to apply spacecraft technology to help people with diseased hearts. As early as 1987, informal meetings began with NASA engineers and Drs. DeBakey and Noon in Saucier's home to discuss the design of a low-cost, low-power, implantable ventricular assist device (VAD). NASA began formal funding of the development of the device four years later, bringing space technology to earth-bound applications.In 1996, MicroMed received an exclusive license from NASA to use this rotary blood pump for cardiovascular applications. MicroMed then began the development of the critical support systems that would allow the device (system) to be approved by regulatory agencies and to be utilized in life-saving applications in humans. European clinical trials of the MicroMed DeBakey VAD began in November 1998 and CE Mark certification was awarded in May 2001. U.S. clinical trials began June 2000 and are going.
As of June 2005, over 330 patients at 46 heart centers in seven countries have been implanted with the device.

Location

8965 Interchange Drive
Houston
Texas
77054
United States of America

Contact

Phone: (713) 838-9210
Fax: (713) 838-9214
Email: micromed@micromedtech.com


News Articles [533 Associated News Articles listed on BioPortfolio]

Traditional Chinese medicine is widely used for cardiovascular disease

(Cardiovascular Innovations and Applications) In this Letter to the Editor, the authors comment on a review article which assesses the efficacy and safety of TCM for cardiovascular disease, as well as...

Use of bivalirudin for anticoagulation in interventional cardiovascular procedures

(Cardiovascular Innovations and Applications) In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 2, 2018, pp. 149-162(14); DOI: 10.15212/CVIA.2017.0045 Zhen Ge, Jaya ...

Multivitamins Don't Appear to Boost Cardiovascular Health

Taking a daily multivitamin is not associated with lower risk for adverse cardiovascular outcomes, according to a meta-analysis in Circulation: Cardiovascular Quality and Outcomes...

Managing dyslipidaemia for the primary prevention of cardiovascular disease

What you need to knowAssess lipid status as part of an overall cardiovascular risk assessment using a risk calculatorRoutinely record a family history of premature cardiovascular disease, and...

Cardiovascular Nutrition Demystified

The authors of this review of key nutritional studies compiled evidence-based information on foods and dietary patterns that support cardiovascular health and demystified those that have incorrectly b...

Omega-3 fats Supplements Effect on Cardiovascular Health: EPA and DHA has little or no effect on Mortality or Cardiovascular Health 

Omega-3 fats Supplements Effect on Cardiovascular Health: EPA and DHA has little or no effect on Mortality or Cardiovascular Health Reporter: Aviva Lev-Ari, PhD, RN   Cochrane Database Syst Rev....

Media registration now open for TCT 2018

(Cardiovascular Research Foundation) Media registration is now open online for TCT 2018 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foun...

Racial/ethnic disparities in cardiovascular health persist in U.S. adults

1. Trends from 1988 to 2014 data suggest that for U.S. adults, cardiovascular health has worsened, and health disparities in race/ethnicity and nativity continue to exist. 2. Although cardiovascular h...

PubMed Articles [1641 Associated PubMed Articles listed on BioPortfolio]

Circulating Wnt inhibitory factor 1 levels are associated with development of cardiovascular disease.

Wnt signaling is involved in atherosclerotic plaque formation directly and indirectly by modulating cardiovascular risk factors. We investigated whether circulating concentrations of Wnt inhibitors ar...

Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have positive effects on weight loss, blood pressure, hyperlipidemia, and glycemic control. They exhibit a broad range of effects on the cardiovas...

3D bioprinting for cardiovascular regeneration and pharmacology.

Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. Compared to traditional therapeutic strategies, three-dimensional (3D) bioprinting is one of the most advanced techn...

Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: a meta-analysis of cardiovascular outcomes trials.

To show long-term cardiovascular safety of the GLP-1 receptor agonists for diabetes patients with cardiovascular risk.

Microbiota-Host Crosstalk: A Bridge Between Cardiovascular Risk Factors, Diet, and Cardiovascular Disease.

Cardiovascular disease is the leading cause of death and is also a major cause of disability worldwide. Indeed, even in well-treated patients for hypertension or dyslipidemia, there is still a high ca...

Clinical Trials [2848 Associated Clinical Trials listed on BioPortfolio]

Cardiovascular Disease Cohort in Guangdong Province

Patients with cardiovascular diseases from Guangdong province will be recruited and followed up for at least 4 years to evaluate the risk factors for cardiovascular-related mortality and d...

Factors Influencing Cardiovascular Prognosis

The purpose of this study is to identify risks for cardiovascular events in a follow up period of 10 years.

Work Organization and Cardiovascular Disease

To determine the combined effects of job strain and social isolation on cardiovascular morbidity and mortality.

Role of Vitamin D in Secondary Prevention of Cardiovascular Events

The purpose of this study is to determine if Vitamin D supplementation helps prevent recurrent cardiovascular events, such as heart attack or stroke, in patients who have already experienc...

Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians

The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.

Companies [608 Associated Companies listed on BioPortfolio]

MicroMed Cardiovascular

In 1984, Dr. Michael DeBakey and Dr. George Noon performed heart transplant surgery on NASA-Johnson Space Center (JSC) engineer David Saucier, following a severe heart attack. Six months later, Saucie...

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate ...

Cardiovascular Consultants Ltd.

Cardiovascular Consultants Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate c...

Embrella Cardiovascular, Inc.

Embrella Cardiovascular™, Inc., is dedicated to creating a new standard-of-care for cerebral embolic protection during cardiovascular procedures. Embrella's Embolic Deflector...

Cardiovascular Consultants

Cardiovascular Consultants is a medical practice that specializes exclusively in the diagnosis, treatment, prevention and management of cardiovascular diseases and conditions. What makes us different ...

More Information about "MicroMed Cardiovascular" on BioPortfolio

We have published hundreds of MicroMed Cardiovascular news stories on BioPortfolio along with dozens of MicroMed Cardiovascular Clinical Trials and PubMed Articles about MicroMed Cardiovascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MicroMed Cardiovascular Companies in our database. You can also find out about relevant MicroMed Cardiovascular Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record